Financial statements Endorfina Group

Balance sheet of Endorfina Group

Company age:

Age:

4 y. 3 m. 17 d.

Share capital:

5 000 PLN

Year	2021	2023
Total assets	1 955 683,10	4 485 829,27
A. Fixed assets	339 217,04	2 317 241,93
B. Current assets	1 616 466,06	2 168 587,34
C. Share capital contributions (basic funds)	0,00	0,00
D. Own shares (stocks)	0,00	0,00
Total liabilities	1 955 683,10	4 485 829,27
A. Equity	-121 043,70	589 253,01
B. Liabilities and provisions for liabilities	2 076 726,80	3 896 576,26
I. Long-term liabilities	-	-
II. Short-term liabilities	-	-

Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.